Loading company…
Qijia Technology develops human-derived 3D bionic microorganisms and research products.
Qijia Technology produces bionic microorganisms of the lung, liver, pancreas, and duodenum, as well as test kits and reagents. It also offers technology and customized services for research, drug development, and precision medicine. Founded in 2022, the company is based in Suzhou, China. It raised angel funding led by Kexun Ruijin Capital in November 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in